Biologics
Recombinant human albumin is a critical component in the manufacture of innovative biopharmaceuticals, particularly for modalities such as cell therapies...
August 09, 2022 | News
Recent Highlights Revenue was $114.6 million for the second quarter, representing a 1% decrease over the corresponding period of 2021. Announ...
August 09, 2022 | News
Biomedical industry is an important part of Wuxi's modern industrial system construction during the 14th Five-Year Plan(2021-2025) period. Its scale topped...
August 09, 2022 | News
Biosynth Carbosynth (“Biosynth”), a supplier of critical materials to the life science industry, announces today that it has signed an agreemen...
August 08, 2022 | News
To meet increasing global demand for cell culture media used in the manufacturing of new vaccines and biologics, Thermo Fisher Scientific has expanded its ...
August 04, 2022 | News
PSS specializes in hardware and software solutions used in defining the makeup and creation of molecular structures. The company provides complete solution...
August 03, 2022 | News
The workshop program included training on the importance of sustainability in manufacturing practices of antibiotics, as well as a presentation of th...
July 27, 2022 | News
CSafe Global, the innovation leader in temperature-controlled shipping solutions for the transport of life-enhancing pharmaceuticals, announced today...
July 26, 2022 | News
The application is for an intravenous (IV) route of administration, with the same dosing regimen, presentation and indication as the reference medicine, Ty...
July 26, 2022 | News
The decision to discontinue the development of fezagepras is based on results from the Phase 1a single ascending dose ("SAD") clinical trial, which indicat...
July 22, 2022 | News
(“Navigo”), a premier protein engineering company and developer of affinity ligands for custom chromatography solutions, today announces succes...
July 21, 2022 | News
The partnership will accelerate stockpiling, channel distribution and hospital access for the amubarvimab/romlusevimab combination in China The ...
July 20, 2022 | News
Sobi® announced an exclusive license agreement with ADC Therapeutics SA to develop and commercialise loncastuximab tesirine for use in haematology and ...
July 11, 2022 | News
Under the partnership, AbTis will have access to WuXi XDC's integrated services for linker and payload manufacturing, ADC conjugation process developm...
July 08, 2022 | News
Most Read
Bio Jobs
News